WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m

Company Overview - bioAffinity Technologies, Inc. is a biotechnology company focused on developing noninvasive tests for early-stage cancer detection [1] - The company has announced a public offering of securities to raise capital [1] Offering Details - The offering consists of 1,921,799 shares of Common Stock priced at $2.50 per share, or pre-funded warrants at $2.493 each [2] - Each pre-funded warrant is immediately exercisable for one share of Common Stock and will expire when fully exercised [2] - The closing of the offering is expected to occur on or about September 30, 2025, pending customary closing conditions [3] Financial Aspects - The aggregate gross proceeds from the offering are expected to be significant, although the exact amount is not specified in the provided text [1] - WallachBeth Capital, LLC is acting as the sole placement agent for this offering [3]